| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.098 | 0.07 |